Earnings Feed
Start Free
Home/Insiders/JOYCE R TODD
JR
SEC Insider//CIK 0001242066

JOYCE R TODD

CIK 00012420662 companiesCORONA, CA
SEC Profile

Transactions

50

Companies

2

Filings

9

CIK

0001242066

Recent Transactions

50 trades
  • Award
    Allergan plc

    Performance-Based Restricted Stock Unit

    2014-07-01+18,662→ 18,662 total
  • Award
    Allergan plc

    Stock Option (Right to Buy)

    2014-07-01+16,983→ 16,983 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-12-06$166.16/sh−7,100→ 40,000 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-12-06$165.51/sh−7,500→ 47,100 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-11-06$158.42/sh−7,500→ 54,600 total
  • Sale
    Allergan plc

    Ordinary Shares

    2013-11-05$157.01/sh−15,000→ 62,100 total
  • Gift
    Allergan plc

    Common Stock, par value $0.0033

    2013-10-08−19,438→ 0 total
  • Gift
    Allergan plc

    Common Stock, par value $0.0033

    2013-10-08+19,438→ 77,100 total
  • Gift
    Allergan plc

    Common Stock, par value $0.0033

    2013-10-07−54,379→ 19,438 total
  • Gift
    Allergan plc

    Common Stock, par value $0.0033

    2013-10-07+54,379→ 57,662 total
  • Disposition to Issuer
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-10-01−3,283→ 0 total
  • Award
    Allergan plc

    Ordinary Shares

    2013-10-01+73,812→ 73,812 total
  • Award
    Allergan plc

    Ordinary Shares

    2013-10-01+3,283→ 3,283 total
  • Disposition to Issuer
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-10-01−73,812→ 0 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30+38,443→ 118,913 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30$144.00/sh−45,101→ 73,812 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-14$137.85/sh−11,000→ 84,470 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-14$138.35/sh−4,000→ 80,470 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-15$91.59/sh−931→ 95,470 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+6,716→ 96,401 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+7,960→ 89,685 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-05$86.46/sh−1,919→ 81,725 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-02$85.54/sh−3,834→ 83,644 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-10-31+5,817→ 87,478 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2012-08-01−574→ 0 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$78.60/sh−2,612→ 88,873 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2012-08-01−2,250→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$35.11/sh+2,250→ 87,485 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$38.92/sh+2,612→ 80,847 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$78.60/sh−2,250→ 82,235 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$38.92/sh+4,388→ 85,235 total
  • Exercise/Conversion
    Allergan Finance LLC

    Incentive Stock Options to Purchase Common Stock

    2012-08-01−3,426→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2012-08-01−4,388→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2012-08-01−2,612→ 0 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$78.60/sh−574→ 81,661 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$78.60/sh−4,388→ 84,485 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$25.64/sh+3,426→ 91,485 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-08-01$25.64/sh+574→ 88,059 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-05-25$26.40/sh+5→ 78,235 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2012-05-25−5→ 0 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-14$59.21/sh−1,067→ 78,230 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+7,698→ 79,297 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+8,356→ 71,599 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-24$58.17/sh−1,625→ 63,243 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-10-30$69.35/sh−1,175→ 64,868 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-08-24$26.14/sh+7,858→ 71,909 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-08-24$35.11/sh+750→ 72,659 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-08-24$26.40/sh+2,854→ 59,909 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-08-24$26.14/sh+4,142→ 64,051 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-08-24$65.46/sh−6,616→ 66,043 total

Companies

2

Recent Filings

9

Address

C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE

CORONA, CA, 92880

View on SEC.gov